Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02517294
Other study ID # #15-17
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 2015
Est. completion date August 2019

Study information

Verified date January 2024
Source Nemours Children's Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Comparison is made between standard nasotracheal tubes and a specially designed nasotracheal tube during nasotracheal intubation in children undergoing general anesthesia for dental surgery.


Description:

The Parker flex-tip, midline-beveled nasotracheal tube theoretically slides past obstruction in the nasopharynx causing less mucosal damage than standard nasotracheal tubes. The investigators aim to test whether mucosal injury during nasotracheal intubation in children undergoing general anesthesia for dental procedures can thus be minimized taking into consideration adenoid size, and differences in nasopharyngeal diameter.


Recruitment information / eligibility

Status Completed
Enrollment 73
Est. completion date August 2019
Est. primary completion date August 2019
Accepts healthy volunteers No
Gender All
Age group 3 Years to 11 Years
Eligibility Inclusion Criteria: - children between the ages of 3-11, ASA 1-3, presenting to Wolfson Children's Hospital (WCH) for dental procedures requiring general anesthesia with nasotracheal intubation. Exclusion Criteria: - ASA >3 - known bleeding disorders - recent or ongoing treatment with blood-thinning medicines - frequent epistaxis - active URI/congestion/rhinorrhea - craniofacial abnormalities prohibiting NTI - known difficult airway - prior nasal surgery/trauma - allergies to any of the medicines used in this study.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Parker flex-tip nasotracheal tube
specially designed nasotracheal tube used for nasotracheal intubation assess nasopharynx for severity of bleeding grade adenoid size
Standard nasotracheal tube
standard nasotracheal tube for nasotracheal intubation assess nasopharynx for severity of bleeding grade adenoid size

Locations

Country Name City State
United States Wolfson Children's Hospital Jacksonville Florida

Sponsors (1)

Lead Sponsor Collaborator
Nemours Children's Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants With Epistaxis Mucosal damage as quantified by presence and severity of bleeding immediately after passage of the NTT through the nasopharynx. within approximately 4hrs of surgery (day of surgery)
Secondary Number of Participants With Nasotracheal Tube Impingement Presence and degree of severe impingement of the nasotracheal tube during nasotracheal intubation perioperative, immediate during intervention - expected 2hrs (day of surgery)
Secondary Number of Participants With Postoperative Epistaxis ongoing nasal bleeding in the recovery unit Participants will be followed for the duration of the hospital stay, an expected average of 6 hours
Secondary Number of Participants With Postoperative Croup evidence of glottic edema/injury in the immediate postoperative time frame end of surgery until time of discharge, approximately 4hrs
Secondary Time to Discharge in Minutes emergence from anesthesia to meeting discharge criteria, approximately 4hrs
See also
  Status Clinical Trial Phase
Completed NCT05334017 - Xylometazoline and Cocaine for Nasal Vasoconstriction Phase 4
Not yet recruiting NCT04519463 - The Effect of Local Anesthesia With Lidocaine During Insertion and Removal of Nasal Packing Early Phase 1
Recruiting NCT01886768 - Double Versus Single Pledget Nasal Anesthesia for Transnasal Endoscopy N/A
Recruiting NCT00390663 - A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children Phase 4
Suspended NCT04054687 - Intranasal TXA for Anterior Epistaxis in the Emergency Department Phase 2
Completed NCT02285634 - The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial. N/A
Completed NCT01485224 - Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia Phase 2
Completed NCT00793117 - The Effect of Packing in Post Operative Management of FESS Phase 4
Recruiting NCT06259292 - Comprehensive HHT Outcomes Registry of the United States (CHORUS)
Recruiting NCT03850964 - Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz) Phase 2/Phase 3
Recruiting NCT05281952 - Medico-economic Evaluation of Management Strategies for Severe Epistaxis N/A
Completed NCT04279288 - The Roles of Hilotherapy in the Management of Epistaxis and Nasal Fractures N/A
Completed NCT03360045 - Comparing Effectiveness of Merocel and Packing With Tranexamic Acid in the Management of Anterior Epistaxis Phase 4
Completed NCT03912051 - Assessment of Performance and Safety of an Asymmetric Balloon in the Treatment of Intranasal Bleeding Managed in an Emergency Setting N/A
Not yet recruiting NCT02677467 - Correlation Between Epistaxis and Cardiovascular Disease N/A
Completed NCT01314274 - Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Phase 2
Terminated NCT01051427 - Control of Epistaxis With Surgiflo N/A
Completed NCT00863356 - Trial of a Novel Chitosan Hemostatic Sealant in the Management of Complicated Epistaxis N/A
Recruiting NCT05269849 - Sirolimus for Nosebleeds in HHT Phase 2
Not yet recruiting NCT05343650 - NOVAPAK Nasal Packing in Shellfish Allergic Patients Phase 4